{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:54:25Z","timestamp":1767905665616,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4225,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009980","name":"Medizinische Universit\u00e4t Innsbruck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.fertnstert.2010.02.041","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T04:37:55Z","timestamp":1270096675000},"page":"2385-2388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Dijana","family":"Had\u017eiomerovi\u0107-Peki\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen Michael","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kay","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Mattle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beata E.","family":"Seeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2010.02.041_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1055\/s-0029-1212004","article-title":"Naltrexone effects on insulin sensitivity and insulin secretion in hyperandrogenic women","volume":"106","author":"Sir-Petermann","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"Suppl 2","key":"10.1016\/j.fertnstert.2010.02.041_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/humrep\/8.suppl_2.168","article-title":"Opiate antagonist treatment of ovarian failure","volume":"8","author":"Wildt","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.fertnstert.2006.01.039","article-title":"Normalization of hyperinsulinemia by chronic opioid receptor blockade in hyperandrogenemic women","volume":"86","author":"Hadziomerovic","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2009.05.012","article-title":"The role of the endogenous opioid system in polycystic ovary syndrome","volume":"92","author":"Eyvazzadeh","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2265.1980.tb01372.x","article-title":"An improved method for the detection of heterozygosity of congenital virilizing adrenal hyperplasia","volume":"12","author":"Lejeune-Lenain","year":"1980","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib8","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1152\/ajpendo.00645.2007","article-title":"Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage","volume":"294","author":"Maniyappa","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/09513590701260193","article-title":"Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance","volume":"23","author":"Nawrocka","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial","volume":"87","author":"Fleming","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jc.2005-1994","article-title":"Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial","volume":"91","author":"Eisenhardt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib12","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/endo-115-4-1645","article-title":"Do testicular opiates regulate Leydig cell function?","volume":"115","author":"Gerendai","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib13","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0015-0282(02)02955-2","article-title":"Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome","volume":"77","author":"Fruzzetti","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib16","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","article-title":"Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome","volume":"90","author":"Palomba","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.02.041_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210003341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210003341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:43:16Z","timestamp":1758008596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028210003341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0015028210003341"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.02.041","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}